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ABSTRACT 
Alström syndrome (AS) is characterised by metabolic deficits, retinal dystrophy, sensorineural 
hearing loss, dilated cardiomyopathy and multi-organ fibrosis. Elucidating the function of the 
mutated gene, ALMS1, is critical for the development of specific treatments and may uncover 
pathways relevant to a range of other disorders including common forms of obesity and type 2 
diabetes. Interest in ALMS1 is heightened by the recent discovery of its involvement in neonatal 
cardiomyocyte cell cycle arrest, a process with potential relevance to regenerative medicine. ALMS1 
encodes a ~0.5 megadalton protein that localises to the base of centrioles. Some studies have 
suggested a role for this protein in maintaining centriole-nucleated sensory organelles termed 
primary cilia, and AS is now considered to belong to the growing class of human genetic disorders 
linked to ciliary dysfunction (ciliopathies). However, mechanistic details are lacking, and recent 
studies have implicated ALMS1 in several processes including endosomal trafficking, actin 
organisation, maintenance of centrosome cohesion and transcription. In line with a more complex 
picture, multiple isoforms of the protein likely exist and non-centrosomal sites of localisation have 
been reported. This review outlines the evidence for both ciliary and extra-ciliary functions of ALMS1. 
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INTRODUCTION 
Alström syndrome (AS) is a rare, recessively inherited disorder that affects numerous organ systems 
[1,2]. Cardinal features include childhood obesity, insulin resistance, cone-rod retinal dystrophy and 
sensorineural hearing loss (SNHL). Type 2 diabetes mellitus and hypertriglyceridemia typically 
develop in childhood or adolescence [2]. Dilated cardiomyopathy (DCM) may arise in infancy, then 
often resolve or at least abate within 3 years. However it may recur, or manifest for the first time, in 
adolescence or adulthood [2]. Other common features include hepatic, renal and pulmonary 
dysfunction, chronic otitis media in childhood, spinal curvature (scoliosis, kyphosis or lordosis) arising 
in adolescence, short stature in adulthood, gastrointestinal disturbances and neurological 
disturbances such as absence seizures [3-7]. Fibrosis of multiple organs is a common finding [4].  
 
Understanding the molecular basis of AS is critical for the development of specific therapies. It may 
also provide new insights into the molecular pathways that go awry in common forms of conditions 
such as obesity and diabetes, which represent major public health concerns [8,9].  
 
The prevalence of AS is estimated at 1-9 cases per million individuals, with approximately 950 
reported cases [10]. It is caused by mutations in ALMS1, a widely expressed 23-exon gene located on 
chromosome 2p13 [11,12]. Over two hundred different AS-causing variants have been identified, of 
which the vast majority are nonsense or frameshift mutations [13,14]. Almost half occur in exon 8 
[14], commensurate with the large size of this exon (6.1 kb, or 49% of the coding sequence). There is 
little evidence of genotype-phenotype correlation, suggesting that the phenotype is modified by 
unknown genetic and/or environmental factors [14].  
 
Intriguingly, biallelic mutations in ALMS1 also cause mitogenic cardiomyopathy, an ultra-rare form of 
DCM characterised by delayed cell cycle arrest of neonatal cardiomyocytes [15,16]. This condition is 
fatal in the first months of life, before other clinical features of AS normally manifest. The few 
mutations reported so far resemble those commonly found in AS, being located in the three largest 
exons (exons 8, 10 and 16) and predicted to cause premature termination of translation. Alms1 also 
appears to be required for timely postnatal cell cycle arrest of cardiomyocytes in mice [15]. Thus, 
mitogenic cardiomyopathy is most likely an extreme form of the infantile DCM often observed in AS 
[15,16]. Mechanisms regulating cardiomyocyte cell cycle arrest are of great interest partly because 
reversing this process could provide a way to stimulate cardiac regeneration after injury [17]. 
 
The ALMS1 protein is a component of the centrosome [18,19], a microtubule (MT)-nucleating 
organelle comprising two centrioles (termed mother and daughter) and a dynamic assembly of 
proteins termed pericentriolar material (PCM). Centrioles are evolutionarily conserved cylindrical 
structures composed of nine triplet MTs, approximately 500 nm in length [20]. Notably, ALMS1 
localises specifically to the base, or proximal end, of these structures [21] (Fig. 1 and Fig. 2).  
 
Centrioles duplicate once per cell cycle, beginning at the G1/S transition, and the two resulting 
centrosomes go on to form the poles of the mitotic spindle [20] (Fig. 2). In interphase, and in some 
terminally differentiated cell types, the centrosome anchors a radial array of MTs that forms the 
basis of an intracellular transport system and influences cell shape, polarity and motility [22,23]. In 
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addition to its classical roles in MT organisation, the centrosome has recently been reported to 
nucleate actin filaments, facilitate endocytic recycling and direct multiple events at the 
immunological synapse [24-26]. It also serves as a hub for components of the cell cycle regulatory 
machinery and proteasome, and has been linked to the DNA damage response (DDR) [27-29]. Of 
note, mutations in genes encoding the centrosomal proteins pericentrin (PCNT) and POC1A are 
associated with severe insulin resistance [30,31], while disruption of the centrosomal protein CEP19 
causes morbid obesity [32]. Mutations in several centriole biogenesis genes cause forms of 
microcephaly [20]. 
 
Centrioles are vital for the assembly of cilia, hair-like projections that are either motile, as in 
multiciliated epithelial cells (MCCs), or non-motile. Most quiescent/terminally differentiated (G0) 
human cells possess a single non-motile (primary) cilium, nucleated by the mother centriole of the 
centrosome (termed a basal body when ciliated) (Fig. 2). The core, or axoneme, of primary cilia 
consists of nine doublet MTs and is enclosed in a lipid bilayer that is continuous with the plasma 
membrane [33]. In many cell types the periciliary membrane forms an invagination called the ciliary 
pocket, which is a site of endocytosis and possibly a docking site for Golgi-derived vesicles [34]. 
Protein synthesis does not occur within cilia and therefore all components must be transported from 
the cell body. A continuously running MT motor-based system termed intraflagellar transport (IFT) 
shuttles cargo molecules from the base to the tip of the cilium and vice versa [33]. Importantly, the 
protein and lipid composition of the ciliary compartment is controlled by a ‘gate’ at the ciliary base, 
part of which is the transition zone (TZ), defined by Y-shaped links extending from the axoneme to 
the ciliary membrane [35] (Fig. 2). 
 
Notably, the light-sensing outer segment (OS) of vertebrate photoreceptors is a highly specialised 
form of primary cilium [36]. The OS is packed with stacks of opsin-containing membrane disks that 
are shed from the distal end and renewed at the base. This requires high-volume trafficking of OS 
components from their site of synthesis in the inner segment (IS) through a narrow structure called 
the connecting cilium (CC), which resembles an extended TZ and is nucleated by a basal body in the 
distal IS [35,36]. Another specialised type of primary cilium is present on hair cells in the developing 
organ of Corti. This ‘kinocilium’ and/or its basal body help to choreograph the formation of 
mechanically sensitive bundles of stereocilia (actin-based structures unrelated to primary cilia), 
which are central to hearing, on the apical cell surface [37,38]. 
 
Interest in primary cilia has widened dramatically in recent years due to accumulating evidence of 
their importance for normal development, tissue homeostasis and energy balance [39-41]. They 
appear to sense and process a variety of molecular cues, helping cells throughout the body to 
respond to changes in the extracellular environment. For example, vertebrate cells require primary 
cilia to respond to Hedgehog (Hh) family ligands, which play crucial roles in development and stem 
cell maintenance [42]. The signalling process involves dynamic localisation of effector transcription 
factors and other pathway components to the ciliary compartment [42]. In growth-arrested cells, 
PDGFRα (platelet-derived growth factor receptor α) and IGF-1R (insulin-like growth factor 1 receptor) 
localise to the ciliary membrane, where they trigger downstream signalling upon ligand-binding, 
leading to responses such as cell cycle re-entry [43-45]. Primary cilia are involved in numerous other 
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signalling pathways, including the Wnt/PCP (planar cell polarity), Notch and TGF-β pathways, and 
may thus serve to integrate multiple signals to ensure an appropriate cellular response [39,46-48]. 
The primary cilia of some cells, such as renal tubule epithelial cells, are thought to sense fluid flow via 
mechanosensitive calcium channel complexes within the ciliary membrane [49]. However, this aspect 
of cilia function has been questioned by recent data [50,49].  
 
While cilia-mediated signalling can influence the cell cycle, ciliation status is in turn controlled by cell 
cycle kinases [51]. Moreover, ciliogenesis and/or cilium length are modulated by inputs from other 
processes such as autophagy, actin cytoskeleton organisation and ciliary signalling itself [51]. 
 
Dozens of genetic disorders have now been linked to cilia dysfunction [52]. Clinical features common 
to several of these so-called ciliopathies include renal cysts, brain abnormalities, polydactyly and 
retinal dystrophy [53-55]. The products of many of the mutated genes have been shown to work 
together in complexes or functional modules, helping to explain both the genetic heterogeneity of 
several ciliopathies and the many examples of genetic overlap [52-54]. ALMS1 loss-of-function has 
been linked to defects in primary cilium formation, positioning and maintenance, leading to AS being 
classified as a ciliopathy [56-59]. However, the precise role of the ALMS1 protein remains uncertain 
and no clear links have been established with other ciliopathy proteins. 
 
The phenotype of AS resembles that of the genetically heterogeneous ciliopathy Bardet-Biedl 
syndrome (BBS), which includes childhood obesity, retinal dystrophy, SNHL and susceptibility to type 
2 diabetes [60,9]. The functions of many BBS proteins converge at an evolutionarily conserved 
protein complex termed the BBSome [61,62], to which various functions have been ascribed 
including promotion of ciliary membrane biogenesis, trafficking of ciliary membrane proteins and 
regulation of IFT particle assembly [61,63-65]. BBS proteins also appear to have extraciliary functions, 
for example mediating trafficking of the insulin and leptin receptors to the plasma membrane 
[66,67].  
 
AS also bears similarity to the phenotype of mice with a mutation in the Tub gene, characterised by 
obesity, insulin resistance, retinal degeneration and SNHL [68,69]. The Tubby protein is implicated in 
trafficking G protein-coupled receptors (GPCRs) and transient receptor potential (TRP) channels to 
neuronal cilia [70,71], and may also act as a transcription factor [72]. 
 
While ALMS1 is known to localise to centrioles/basal bodies [19,21,56,57], localisation to non-
centrosomal sites has also been reported and recent studies have implicated the protein in several 
cellular processes including endosomal trafficking, actin organisation and transcription [73-77]. On 
broader scales, ALMS1 has been implicated in neuronal migration, maintenance of cellular 
quiescence, adipogenesis, spermatogenesis, maintenance of pancreatic β-cell mass, adaptive 
thermogenesis and, as noted above, cell cycle arrest of cardiomyocytes [15,16,57,78-82].  
 
This review focuses on the quest to understand AS at the molecular and cell biological levels. In 
addition to results from mouse model- and cell-based functional studies, recent insights into ALMS1 
gene regulation and the interaction network of the encoded protein are highlighted. 
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THE ALMS1 PROTEIN 
ALMS1 is a large (>4000 residue) protein that lacks known catalytic domains. It has several sequence 
features of unknown function, including a large tandem repeat domain (TRD), three short predicted 
coiled-coil domains and a stretch of ~130 residues at the C-terminus dubbed the ALMS motif (Fig. 3). 
The ALMS motif is the only region that shares obvious sequence similarity with other human 
proteins. It was defined on the basis of similarity to mammalian orthologues of C10orf90/FATS 
(Fragile site-Associated Tumour Suppressor) [11], reportedly an E2-independent ubiquitin ligase 
which stabilises p53 in response to DNA damage [83] and may localise to the centrosome and actin 
cytoskeleton [21]. A more divergent ALMS motif was subsequently identified at the C-terminus of 
CEP295/KIAA1731 [21], a large protein implicated in centriole assembly and maintenance [21,84-87]. 
Notably, the CEP295 ALMS motif appears to bind MTs [84]. Deletion analysis of ALMS1 suggests that 
its ALMS motif may contribute to centrosome-targeting [21]. However, the motif is not essential for 
centrosomal localisation of either ALMS1 or CEP295 [21,84,85].  
 
Orthologues of ALMS1 are readily detectable in chordates, although most of the N-terminal half of 
the protein, which mainly comprises the TRD, appears to be specific to mammals [21; unpublished 
observation]. The proteomes of many ciliated eukaryotes, including unicellular organisms such as 
Tetrahymena and Paramecium, contain predicted proteins with C-terminal ALMS motif-like 
sequences, suggesting that the motif has an ancient, conserved function relating to centrioles or cilia 
[21]. 
 
Experimentally defined sites of post-translational modification in ALMS1 include a cluster of 
ubiquitination sites around the third predicted coiled-coil domain [88] and a DNA damage-regulated 
phosphorylation site (S2781) [89] (data accessed via PhosphoSitePlus [90]). Regarding the latter, it is 
notable that a genome-wide RNAi screen identified ALMS1 as one of ~800 genes required for 
resistance to ionising radiation in U2OS cells [91]. Other ciliopathy-associated proteins have been 
linked to DDR signalling [92] but the potential role of ALMS1 in this process remains to be 
investigated. 
 
REGULATION OF ALMS1 GENE EXPRESSION 
ALMS1 is widely expressed [11,12,19,93] but its level of expression is context-dependent. For 
example, Alms1 mRNA declines during in vitro differentiation of 3T3-L1 preadipocytes [94,79], 
possibly related to the observation that mature adipocytes lack primary cilia [95]. Conversely, it 
increases during terminal differentiation of neonatal mouse cardiomyocytes [15] and in cell culture 
conditions that promote cell cycle exit and primary cilium formation (i.e. serum-starvation or 
confluency) [57,96,97]. It also increases during differentiation of MCCs in vitro [98,99], possibly 
reflecting a requirement for the protein at the hundreds of basal bodies assembled in these cells. 
 
The ALMS1 promoter contains an evolutionarily conserved consensus binding site for ciliogenic RFX 
(regulatory factor X) transcription factors, three of which (RFX1, RFX2 and RFX3) have been 
implicated in activating ALMS1 transcription in response to serum-starvation [96]. Involvement of 
RFX proteins is supported by ChIP-Seq data from other studies, for example for murine Rfx1 and Rfx3 
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in neural progenitors and Min6 insulinoma cells, respectively [100,101] (data accessed via the 
Cistrome Data Browser [102]). Vertebrate RFX2 and RFX3 have well-established roles in regulating 
ciliary genes in various tissues [103], while RFX1 has recently been reported to stimulate 
transcription of key ciliogenic genes downstream of leptin in hypothalamic neurons and to regulate 
other ciliary genes [104,105]. However, it should be noted that RFX1 and RFX3 also regulate non-
ciliary genes [100,103,106]. 
 
In Xenopus differentiating MCCs, Alms1 transcription appears to be upregulated by a protein 
complex containing Multicilin and the DNA-binding transcription factor E2f4 [99]. Many of the genes 
targeted by this complex in MCCs encode factors that, in proliferating cells, are known to be involved 
in centriole biogenesis [99]. 
 
PROTEIN-PROTEIN INTERACTIONS AND PROXIMITY INTERACTIONS 
Numerous candidate ALMS1-interacting proteins have been reported. Members of the α-actinin 
family of actin-binding proteins were identified in yeast two-hybrid (Y2H) screens using the C-
terminal region of murine Alms1 as bait, and co-immunoprecipitation data supported an interaction 
with α-actinin-4 (Actn4) in mouse kidney [76]. ACTN4 and another protein identified in the same Y2H 
screen (myosin Vb) are components of the cytoskeleton-associated recycling or transport (CART) 
complex, involved in endosomal recycling [107]. Myo5b also interacts with a key regulator of ‘slow’ 
recycling pathways, Rab11 [108], and shares the ability of Myo5a to interact with the ciliopathy 
protein RPGRIP1L [109]. α-Actinins and another protein identified in the same Y2H screen, Rilpl1 
(Rab-interacting lysosomal protein-like 1), have also been implicated in ciliary roles [110,111]. 
 
An ongoing human interactome study based on affinity purification coupled with mass spectrometry 
(AP-MS) [112,113] has identified 18 potential ALMS1 interactors including the BBSome subunit BBS7; 
AVIL (advillin), which severs actin filaments and influences ciliogenesis [114]; RABL2A, the mouse 
orthologue of which binds CEP19 and IFT proteins [115-117]; CDC16 (cell division cycle 16), a 
component of the anaphase-promoting complex; DNM3 (dynamin 3), involved in membrane fission 
[118]; TFDP3, a dimerization partner of E2F transcription factors [119]; and dysbindin/DTNBP1 
(dystrobrevin binding protein 1), a subunit of the BLOC-1 complex that is involved in recycling 
endosome formation and GPCR trafficking in the lysosomal pathway, and is required for trafficking of 
polycystin-2 to cilia [120-122]. Another global AP-MS study identified an interaction with 
VCIP135/VCPIP1 (valosin-containing protein-interacting protein 1) [123], a deubiquitinating enzyme 
which functions in membrane fusion [124,125]. 
 
Other AP-MS studies have identified ALMS1 as a possible binding partner of the RNA polymerase II 
(RNAPII) subunit RPB1 [77]; the serine-arginine protein kinase SRPK2 [126]; GPCR-associated sorting 
protein 2 (GPRASP2), implicated in ciliary translocation of Smoothened, a key component of the Hh 
signalling pathway [127,128]; and CEP192, a protein involved in centrosome biogenesis [129]. 
Consistent with the latter finding, ALMS1 was labelled by a CEP192-biotin ligase fusion (bait) in a 
proximity-dependent biotinylation (BioID) study [130]. However, because ALMS1 was labelled by 
baits representing several centriole duplication factors (PLK4, CEP152, CPAP, CEP63 and KIAA0753), it 
was suggested that at least in some cases this may reflect a dispersed localisation or high mobility 
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within the centrosome [130]. In a BioID study focusing on centrioles, cilia and centriolar satellites, 
centriole assembly factors including CEP152, CPAP, CEP135 and SASS6 were among 11 baits 
producing high confidence proximity interactions with ALMS1 [131]. Collectively, these data may 
indicate that ALMS1 is present at the proximal ends of nascent procentrioles. However, the timing of 
ALMS1’s recruitment to newly forming centrioles is unknown, and it remains to be determined if the 
BioID results reflect physical interactions. 
 
BioID has also identified ALMS1 as a potential interactor/substrate of the E3 ubiquitin ligase SCFβ-TrCP1 
[132], and of separase [133], a protease that mediates separation of sister chromatids, and of 
newborn centrioles from their parents, in mitosis [134]. Another recent BioID study suggests links to 
proteins involved in the Hippo signalling pathway (LATS2 and AMOT; [135]). An updated list of 
reported physical and proximity interactions is available online at thebiogrid.org [136]. 
 
ALMS1 FUNCTION 
 
Cilium formation/maintenance  
The notion that ALMS1 has a ciliary role probably first arose when BBS was linked to basal 
body/primary cilium dysfunction [137]. As outlined below, supporting evidence has emerged from 
analyses of ALMS1-deficient mice and ALMS1-depleted cultured cells, although not to date from 
analyses of AS patient fibroblasts. 
 
Alms1GT/GT mice  
Mice with a gene trap in intron 13 (Alms1GT/GT mice) appear to form cilia normally, based on electron 
microscopy analysis of renal collecting ducts, photoreceptors and airway epithelium [93]. However, 
within photoreceptors a fraction of rhodopsin mislocalises to the outer nuclear layer (ONL) and 
vesicles accumulate in the IS, suggesting a defect in the tethering, docking or fusion of rhodopsin 
carrier vesicles at the base of the connecting cilium [93] (Fig. 4a). Photoreceptor degeneration is 
evident by the age of 24 weeks in these mice. 
 
In the developing organ of Corti in Alms1GT/GT mice, the kinocilium of outer hair cells (OHC) is often 
mis-positioned and some stereociliary bundles display defects in shape and orientation [56] (Fig. 4b). 
These abnormalities, which resemble those seen in mouse models of BBS [138], implicate ALMS1 in 
cilium-dependent PCP signalling [56]. The kinocilium appears to be required for normal bundle shape 
and orientation in individual OHCs, but not for polarisation of core PCP proteins [38]. Only ~20% of 
OHC bundles are affected in Alms1GT/GT mice, suggesting that Alms1 dysfunction renders this cell type 
susceptible to a stochastic event during development [56]. Progressive loss of OHCs also occurs and 
appears to be the main cause of hearing loss in these mice, although it is unclear if this is directly 
related to the observed bundle abnormalities [56]. 
 
Alms1L2131X/L2131X mice 
Mice with an N-ethyl-N-nitrosourea (ENU)-induced nonsense mutation in exon 10 (Alms1L2131X/L2131X 
mice) exhibit loss of renal primary cilia by six months of age [57]. Notably, only certain proximal 
tubules are affected, suggesting that an additional, somatic, event may be required [57]. Cilia-loss 
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correlates with increased proliferation and apoptosis of tubule epithelial cells [57] but whether it 
triggers these changes remains unknown (Fig. 4c). Rhodopsin mislocalises to the ONL in some 
photoreceptors of Alms1L2131X/L2131X mice, similar to Alms1GT/GT mice. Also of note, sperm flagella, 
which are structurally similar to cilia, are reduced in number and length compared to wild-type [57]. 
 
Alms1foz/foz mice 
Mice with a truncating mutation in exon 8 (Alms1foz/foz mice) have also been reported to exhibit age-
dependent loss of primary cilia, in this case on hypothalamic neurons [58]. The loss begins between 
four days and three weeks of age, based on staining for AC3 (adenylate cyclase type 3), and seems to 
occur rapidly because the remaining cilia are not significantly shorter than those of control mice (Fig. 
4d). Loss of cilia was supported by staining for three additional ciliary proteins (Sstr3, Mchr1 and 
Arl13b). Because the markers used are not core structural components of cilia, it is formally possible 
that their trafficking to cilia is blocked in subsets of Alms1foz/foz neurons. However, on the reasonable 
assumption that cilia are lost, the detection of Sstr3 and Mhcr1 in remaining cilia [58] is notable 
because ciliary localisation of these GPCRs is abrogated in Bbs and tubby mutant mice [71,139]. 
 
Hypothalamic neuronal primary cilia are implicated in regulating satiety responses (via factors 
including Mchr1 and AC3) [139-141] and Alms1foz/foz mice are reportedly hyperphagic before 
becoming obese [82]. Thus, resorption or degeneration of these cilia may contribute to the 
development of obesity in these mice [58]. Although Alms1GT/GT and Alms1L2131X/L2131X mice also 
become obese [93,57], preceding hyperphagia has not been documented and it is not known if loss 
of hypothalamic primary cilia occurs. Another notable feature of Alms1foz/foz mice is the degeneration 
of germ cells during spermatogenesis, particularly at the round-to-elongating stage during which 
flagella assembly occurs, although the assembly process is completed in some cells [82]. 
 
In summary, the initial formation of primary cilia appears normal in all three mouse models reported 
to date, consistent with their lack of obvious developmental phenotypes. However, age-dependent 
loss of primary cilia has been observed in Alms1L2131X/L2131X and Alms1foz/foz mice. Cilia-related deficits 
in a third model (Alms1GT/GT mice) include mislocalisation of rhodopsin and mispositioning of OHC 
kinocilia. Whether differences in the occurrence/timing of cilia-loss seen in these studies reflect the 
nature of the mutations, the focus on different cell types, or other factors, remains uncertain. 
 
AS patient fibroblasts and ALMS1 siRNA-treated cells 
The formation of primary cilia seems to be unaffected in AS patient fibroblasts in vitro [19,76,142]. 
Hh and PDGFA signalling, both of which act through the cilium, also appear to be normal [142]. In 
stark contrast, transient RNAi-mediated depletion of ALMS1 has been reported to cause severe 
defects in ciliary structure. Ball-like staining of the ciliary axoneme marker acetylated tubulin was 
apparent in Alms1-depleted IMCD3 (mouse inner medullary collecting duct) cells, using two different 
siRNAs [57]. These malformed cilia were also functionally defective, based on measurement of 
intracellular calcium in response to fluid flow. A cDNA construct encoding the N-terminal 40% of 
Alms1 was reported to rescue cilium formation, although the effect was not quantified and the 
subcellular localisation of this N-terminal fragment was not reported [57]. Knockdown of ALMS1 in 
hTERT-RPE1 (human telomerase-immortalised retinal pigmented epithelium) cells has similarly been 
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reported to result in the appearance of morphologically abnormal, stunted cilia [59], although 
whether the two siRNAs tested produced exactly the same effect is unclear. 
 
Notably, Alms1 immunofluorescence is clearly visible at centrosomes in Alms1L2131X/L2131X and 
Alms1GT/GT mice, but not Alms1-depleted IMCD3 cells, using an N-terminal antibody [56,57]. 
Moreover, Alms1 siRNA treatment has been reported to inhibit ciliogenesis in Alms1L2131X/L2131X 
embryonic fibroblasts [57]. These findings suggest that RNAi suppresses ALMS1 expression more 
comprehensively than truncating mutations, at least in murine cells, offering a possible explanation 
for the striking effects on cilium morphology [57]. If this is the case, then true null mutations in 
ALMS1 would likely disrupt ciliogenesis (assuming lack of adaptive compensation), leading to severe 
developmental defects and possibly embryonic lethality. 
 
On the other hand, it could be argued that additional data are needed to confirm that the 
catastrophic ciliary defects seen in siRNA-treated cells are due to depletion of ALMS1. It is notable 
that Alms1 immunostaining was not detected in Alms1foz/foz neurons [58], nor in fibroblasts from 14 
out of 16 AS patients with biallelic nonsense/frameshift mutations [142], implying absence of 
residual protein function. Nevertheless, expression of ALMS1 isoforms lacking the antibody epitopes 
used for detection cannot be excluded in these cases. 
 
Maintenance of centrosome cohesion and composition 
The specific localisation of ALMS1 to the proximal ends of centrioles [21] is unusual for a ciliopathy-
associated protein. Filaments emanating from this zone make up the centrosome linker, a structure 
that helps to maintain the close pairing of mother and daughter centrioles, termed centrosome 
cohesion ([143,144]; Fig. 2). RNAi data have implicated ALMS1 in the proximal end-recruitment of 
CEP250/C-Nap1 [21], a protein that anchors the centrosome linker and a related structure called the 
ciliary rootlet (Fig. 2 and Fig. 5a) [143-145]. Consistently, centrosome cohesion appears to be 
compromised in ALMS1-depleted cells ([21]; Fig. 5a). 
 
There is some evidence that mutations in human CEP250 lead to retinal dystrophy and SNHL [146-
148], and CEP250 is known to interact with proteins implicated in rhodopsin trafficking (NEK2 and 
NINL) [149-152]. It is also worth noting that human Tubby and the core PCP protein Dvl2 localise to 
the rootlet [153,154]. CEP250 does not seem to be required for primary cilium formation or 
maintenance [59,155-157], although a recent conflicting report suggests that ciliogenesis cannot 
proceed if centrosome cohesion is lost [158]. Another recent study showed that CEP250 contributes 
to retaining the cilium in a submerged state, affecting its capacity to sense external cues [159]. 
CEP250 appears to be crucial for the recruitment of several proteins to centriole proximal ends, 
including Girdin (Girders of actin filaments) and a group of proteins that associate also with the distal 
region of the mother centriole (NEK2, ninein, CEP170, p150glued and KIF2A) [159-162]. Thus, 
recruitment of these proteins to centriole proximal ends may depend indirectly on ALMS1, and there 
is evidence of this in the case of NEK2 ([162]; Fig. 5a).  
 
In addition to CEP250 and NEK2, centrosomal levels of the PCM protein PCNT are modestly reduced 
in ALMS1-depleted hTERT-RPE1 cells [21]. Like ALMS1, PCNT has been implicated in ciliogenesis, 
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maintenance of centrosome cohesion and adipogenesis [31,163,164]. Moreover, PCNT mutations 
lead to severe insulin resistance, dyslipidemia and diabetes in the context of microcephalic 
osteodysplastic primordial dwarfism type 2 (MOPDII) [31]. Centrosomal recruitment of PCNT is 
mediated in part by polyglutamate chains added post-translationally to centriolar tubulin [165], 
making it tempting to speculate that the N-terminal polyglutamate tract of ALMS1 could act in a 
similar fashion. 
 
It is not hard to imagine ALMS1 performing a structural role such as tethering other proteins to the 
base of centrioles. Alternatively, it could influence centrosome composition indirectly. Recent data 
indicate that pericentrosomal levels of centriolar satellites, key regulators of centrosome 
composition, are enhanced in ALMS1-depleted cells [131]. However, it should be emphasized that 
the above findings are based on RNAi and await confirmation by rescue experiments and genetic 
studies. 
 
Actin cytoskeleton organisation 
Immunofluorescence analysis of filamentous actin in AS patient fibroblasts revealed the presence of 
non-uniform and stunted filaments, in addition to stress fibres similar to those of control cells [76]. A 
separate electron microscopy-based analysis of AS fibroblasts revealed abnormal orientation of 
microfilaments (a.k.a. actin filaments) [75]. Also of note, these cells displayed a reduced ability to 
migrate in 3D culture, strong anchoring of cytoplasmic extensions, increased production of 
extracellular matrix (ECM), an extended cell cycle and resistance to chemically induced apoptosis 
[75]. It is not known how ALMS1 dysfunction leads to defects in F-actin organisation although, as 
noted above, physical interactions with actin-binding/regulatory proteins have been reported 
[76,113]. It remains to be investigated if ALMS1 is important for the recently discovered ability of 
centrosomes to nucleate actin filaments [25]. 
 
Endosomal trafficking of transferrin and Notch 
Impairments in the trafficking and recycling of endocytosed transferrin (Tf) have been noted in AS 
patient fibroblasts [76]. The transferrin receptor showed enhanced accumulation in the 
pericentrosomal region, while uptake of labelled transferrin was slightly impaired and its exit from 
the recycling compartment delayed compared to control fibroblasts. The positioning of the 
pericentrosomal endosomal recycling compartment, marked by Rab11, was unaffected. In the same 
study, an antibody raised to a C-terminal peptide of murine Alms1 was found to stain the contractile 
ring and cleavage furrow (sites to which the endosomal recycling machinery is recruited) as well as 
cytoplasmic ACTN1-immunopositive dense bodies, but not centrosomes, in MDCK (Madin-Darby 
canine kidney) cells. Based on these and additional data mentioned above, it was speculated that 
ALMS1 may be required for the cytoskeletal architecture that enables endosomal recycling, and/or 
function together with the CART complex to facilitate rapid endosome transport along actin 
filaments ([76]; Fig. 5b). 
 
Endosomal trafficking of Notch, a receptor involved in multiple processes including cell fate 
determination during development, also appears to be disrupted in ALMS1-deficient cells, although 
in this case the recycling branch of the pathway was not significantly affected [74]. Specifically, Notch 
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was reported to accumulate in late endosomes in ALMS1-depleted hTERT-RPE1 cells and a slight (1.2-
fold) but statistically significant increase in expression of the Notch target gene HES5 was detected in 
ALMS1-depleted HEK293 cells (Fig. 5b). Overactivation of Notch signalling could have wide-ranging 
impacts relevant to the pathogenesis of AS including extending the proliferative window of neonatal 
cardiomyocytes and exacerbating selective insulin resistance in the liver [166,167]. Notch signalling 
has been reported to utilise the primary cilium [168], however ALMS1 does not appear to be 
required for localisation of NOTCH1 to the basal body or cilium [74]. Of note, depletion of BBS 
proteins similarly leads to accumulation of Notch in late endosomes but also impairs endocytic 
recycling and basal body/ciliary localisation of the receptor [74]. 
 
GLUT4 trafficking and/or adipogenesis 
Indications that ALMS1 influences endocytic recycling suggested that it could have a role in GLUT4 
(glucose transporter type 4) trafficking [76]. Insulin-stimulated movement of GLUT4 from 
intracellular stores to the plasma membrane in fat and muscle cells plays a key role in maintaining 
whole-body glucose homeostasis [169]. Analysis of adipose tissue from Alms1GT/GT  mice revealed that 
the level of GLUT4 in the plasma membrane fraction was higher in the basal than the insulin-
stimulated state, and that the overall level of GLUT4 was reduced compared to control [73]. 
Moreover, Alms1GT/GT preadipocytes differentiated in vitro showed reduced insulin-stimulated GLUT4 
translocation and glucose uptake compared to wild type cells [73]. Phosphorylation of Akt, the main 
insulin-regulated signal transducer for GLUT4 translocation, appeared to be unaffected in Alms1GT/GT 
adipose tissue, suggesting that ALMS1 functions either downstream or independently of Akt [73]. 
The actin cytoskeletal defects observed in patient fibroblasts and the reported physical interaction 
between Alms1 and Actn4 [76] may provide clues to the underlying mechanism [73,170]. However, 
as outlined below, there are conflicting data regarding the importance of Alms1 for insulin-
stimulated glucose uptake (and, by implication, GLUT4 trafficking). 
 
Earlier RNAi experiments using 3T3-L1 preadipocytes indicated that Alms1 is important for 
adipogenic differentiation [79], whereas preadipocytes from Alms1GT/GT mice showed no such 
differentiation defect in vitro [73]. This discrepancy may reflect cell line specificity or a difference in 
the level of residual Alms1 function present, as suggested to explain the ability of patient fibroblasts 
and Alms1 mutant mice to assemble morphologically normal primary cilia [57]. Of note here, 
signalling pathways with positive (IGF-1R) and negative (Wnt and Hh) effects on adipogenesis utilise 
cilia [95,171,45], but whether ALMS1 deficiency affects ciliation during this process is not known. 
 
Similar to the later analysis of Alms1GT/GT mouse adipose tissue, Alms1 did not appear to be required 
for proximal insulin signalling in 3T3-L1 adipocytes [79]. However, neither did it seem to be required 
for insulin-stimulated glucose uptake, since the modest decreases observed in Alms1-depleted 3T3-
L1 adipocytes could be accounted for by impaired differentiation [79]. This study suggests an 
alternative mechanism contributing to insulin resistance in AS. Namely, that a partial defect in 
adipogenesis would reduce the ability of adipose tissue to expand in situations of caloric excess, 
leading to the development of insulin resistance at other sites [172,79]. However, since the severity 
of insulin resistance in AS often exceeds that in congenital generalized lipodystrophy, other factors 
are likely involved [79].  
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Transcription 
As noted earlier, ALMS1 has been identified as a potential binding partner of the RNAPII subunit 
RPB1 [77]. In the same study, punctate nuclear (and cytoplasmic) anti-ALMS1 staining was observed 
with two different antibodies in cryosections of HeLa cells and murine tissues, and immunolabelling 
of ALMS1 was found to block subsequent immunolabelling of RPB1, suggesting colocalisation (based 
on antibody steric hindrance). Supporting the biological relevance of these findings, ALMS1 
knockdown reduced global transcription levels in HeLa cells. Thus, these data suggest that ALMS1 
localises to the nucleus and is important for sustaining the transcriptional activity of RNAPII [77]. 
Deficiency of ALMS1 has been associated with altered gene expression profiles in other systems 
[75,173,174], however it is unclear if these effects are direct. Of note, the transcriptional program 
associated with ciliogenesis/confluency was unaffected in Alms1-depleted IMCD3 cells [57], 
suggesting that impaired transcription is unlikely to underlie the severe ciliary defects observed in 
these cells. 
 
CONCLUSIONS 
Perhaps not surprisingly given the complexity of the AS phenotype, ALMS1 appears to have multiple 
functions. The photoreceptor phenotype of Alms1GT/GT mice hints at involvement in the transition 
from vesicular to intraciliary transport, a process controlled in part by the small GTPase Rab8 and in 
which ciliopathy proteins including CC2D2A and BBS proteins have been implicated [61,151,175,176]. 
Other studies suggest that ALMS1-deficiency leads to a wider impairment of vesicular transport, 
affecting Notch signalling, GLUT4-mediated glucose uptake and potentially many other processes. It 
remains unclear if the underlying cause of these transport deficits is disruption of the actin 
cytoskeleton (as observed in AS patient fibroblasts), of MTs, or of specific trafficking steps. Following 
up on leads from protein-protein interaction data, recently significantly enriched by a human 
interactome study [113], may help to clarify this. Notably, perturbation of either the actin 
cytoskeleton or the endocytic recycling pathway can affect ciliogenesis and cilium length [114]. 
However, as discussed earlier, the importance of ALMS1 for cilium structure remains somewhat 
uncertain, partly because many disease-causing mutations may not lead to complete loss of protein 
function. 
 
However, as discussed earlier, the importance of ALMS1 for cilium structure remains somewhat 
uncertain, due in part to the lack of obvious ciliary defects in patient fibroblasts and the limited 
examples of age-dependent cilia-loss observed to date in mouse models. 
 
  
The application of proximity labelling has raised the intriguing possibility that ALMS1 interacts with 
centriole assembly factors, similarly to the ALMS motif-containing protein CEP295/KIAA1731. 
Although centriole-loss has not been observed in ALMS1-deficient cells, a subtler defect, which could 
affect both ciliary and extraciliary functions of the centrosome, remains a possibility. Loss of the 
centrosome cohesion protein CEP250/C-Nap1 from ALMS1-depleted centrioles could be a 
manifestation of such a defect. Indications that ALMS1 has roles in transcription [77] and possibly the 
DDR [91,89] suggest additional areas for further research. 
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Immunofluorescence data placing ALMS1 at locations such as the nucleus and cleavage furrow 
support the idea that multiple isoforms of the protein exist. However, it is important to note that 
these localisation data have yet to be confirmed by, for example, parallel analysis of ALMS1-depleted 
cells. Further work is needed to explore the range of ALMS1 transcripts produced by cells, their 
functional capacities and potential relevance to phenotypic variability in AS. 
 
It remains plausible that primary cilium or basal body dysfunction contributes to many aspects of the 
AS phenotype including obesity, retinal dystrophy, hearing-loss, kidney dysfunction, neurological 
disturbances and fibrosis [52,78,48]. Moreover, data implicating pancreatic β-cell primary cilia in the 
regulation of insulin secretion [177] raise the possibility that a ciliary defect contributes to the 
progressive failure of insulin secretion that occurs in AS and is the major factor in progression to 
diabetes [178]. Dysfunction of motile cilia could contribute to other clinical aspects of AS including 
respiratory problems, chronic otitis media in childhood and abnormal spinal curvature in adolescence 
[179,180]. Although evidence that ALMS1-deficiency directly impacts motile cilia is lacking at present, 
upregulation of ALMS1 expression during MCC differentiation is intriguing. 
 
Whether a ciliary defect could impair cardiomyocyte cell cycle arrest, leading to infantile 
DCM/mitogenic cardiomyopathy, is uncertain. Signalling pathways linked to primary cilia in other 
contexts (e.g. Hippo, Wnt, IGF-1R, Notch) are among the many factors thought to regulate this arrest 
[181,167]. However, mammalian cardiomyocytes appear to lose the ability to assemble a primary 
cilium shortly after birth, concomitant with loss of centrosome integrity and redistribution of 
centrosomal proteins to the nuclear periphery [182].  
 
Clearly, much remains to be learned about this giant protein. The identification of bona fide 
interacting partners remains an important goal, as does, more straightforwardly, confirmation of 
extra-centrosomal sites of localisation. Structural data may reveal homologies not detectable at the 
sequence level, helping to reveal the functions of individual domains. The establishment of zebrafish 
models of AS [80,173] will facilitate in vivo functional studies, the identification of genetic 
interactions and therapeutic testing/screening. However, the relatively poor evolutionary 
conservation of ALMS1 is a limitation of non-mammalian models. Gene editing and the generation of 
patient-derived induced pluripotent stem cells are likely to play important roles in resolving the 
functions of the human protein.  
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Fig. 1 ALMS1 is a centrosomal protein that localises specifically to the proximal end of 
centrioles/basal bodies. Top (l-r): immunofluorescence microscopy images showing centrosomal 
staining pattern of ALMS1 in hTERT-RPE1 cells in interphase and mitosis, and in fetal human kidney. 
The mitotic hTERT-RPE1 cell was co-stained with an antibody to acetylated α-tubulin (Ac-tubulin), 
which marks centrioles and spindle microtubules. DNA was stained with DAPI (blue). Scale bars, 10 
μm. Bottom: ciliated hTERT-RPE1 cell stained with antibodies to ALMS1, the PCM component γ-
tubulin and the centriole/axoneme component Ac-tubulin. Localisation of ALMS1 to centriole/basal 
body proximal ends has been confirmed by super-resolution microscopy [21]. DC, daughter centriole; 
BB, basal body. Scale bar, 1 μm. 
 
 
Fig. 2 Primary cilia and the centrosome cycle. In G1 phase of the cell cycle the centrosome contains 
one mother and one daughter centriole (MC, DC), the MC being distinguished by appendages at its 
distal end. In S and G2 phases, one procentriole assembles orthogonally to each pre-existing 
centriole [20]. ALMS1 (green circles) localises to the proximal ends of the MC and DC, from where the 
centrosome linker extends; it is not known if ALMS1 localises to procentrioles (green question 
marks). The centrosome linker is dissolved before mitotic entry, facilitating bipolar spindle formation, 
and reassembles at the end of mitosis when the newly built centriole disengages from its parent’s 
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side. The pre-existing DC acquires appendages in late G2 or M phase and functions as an MC in the 
following cell cycle [20]. Upon cell cycle exit (G0) most cell types generate a primary cilium. The MC 
alone is competent to form a cilium, and in this role is termed a basal body (BB). Cilia are typically 
resorbed upon cell cycle re-entry. However, in some cell types/contexts they may persist, or re-
assemble in interphase, before disassembling prior to mitosis (not shown) [183]. CiPo, ciliary pocket; 
DAP, distal appendages; sDAP subdistal appendages. 
 
Fig. 3 Sequence features of ALMS1. a Representation of the primary structure showing recognised 
features in relation to exon boundaries. The N-terminal polyglutamate (PolyE) tract is polymorphic 
[12] and is followed by seven alanine residues. Short lengths of the polyE tract have been associated 
with an increased risk of early-onset myocardial infarction in the general population [184]. CC, 
predicted coiled-coil domain; LZ, leucine zipper motif; pNLS, potential nuclear localisation signal. 
Numbers below each feature refer to amino acid positions. b Consensus sequence of the tandem 
repeat. The repeats are relatively rich in serine and proline residues and have little secondary 
structure-forming potential. Consensus generated using WebLogo [185], based on an alignment with 
seven gaps removed to facilitate display. 
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Fig. 4 Selected cellular phenotypes observed in mouse models of AS. a Large membrane-bound 
vesicles accumulate in the inner segment (IS) of adult Alms1GT/GT rod photoreceptors. 
Immunofluorescence data indicate shortening of the inner and outer and segments (OS) at 24 weeks 
of age and mislocalisation of rhodopsin at 7 and 24 weeks of age [93]. Similar mislocalisation of 
rhodopsin occurs in Alms1L2131X/L2131X retina [57]. It is not known if mislocalised rhodopsin is vesicle-
associated. b In neonatal Alms1GT/GT mice, some outer hair cells (OHC) in the organ of Corti display 
misoriented and/or misshapen bundles of stereocilia (actin-based structures) and mislocalisation of 
kinocilia (a type of primary cilium), indicating impaired cilium-dependent planar cell polarity. Inner 
hair cell (IHC) bundles appear unaffected [56]. c Representation of kidney proximal tubule epithelium 
in six month-old WT and Alms1L2131X/L2131X mice, based on data indicating tubule dilation and loss of 
primary cilia coupled with increased proliferation (Ki67 staining) and apoptosis (TUNEL staining) in 
the mutant [57]. d Loss of hypothalamic neuronal primary cilia occurs by three weeks of age in 
Alms1foz/foz mice [58]. 
 
32 
 
 
 
Fig. 5 Potential involvement of ALMS1 in centrosome cohesion and endosomal trafficking. a ALMS1 
has been implicated in anchoring the centrosome cohesion protein C-Nap1/CEP250 to centriole 
proximal ends [21], akin to CEP135 [186]. Loss of CEP250 from these sites in ALMS1-depleted cells is 
accompanied by centrosome splitting [21]. The CEP250-associated kinase NEK2 is also lost, but not 
from the distal portion of the mother centriole (MC) [162]. The effect shown here on rootletin-
containing fibres is inferred based on the rootletin-anchoring function of CEP250 [143,144]. DC, 
daughter centriole. b Endosomal trafficking of Notch and TfR (transferrin receptor) appears to be 
altered in ALMS1-deficient cells. Notch accumulates in late endosomes (LE) in ALMS1-depleted cells, 
potentially leading to increased signalling [74]. Clearance of Tf is delayed in fibroblasts derived from 
AS patients, suggesting impaired TfR recycling. Reported physical interactions between ALMS1 and 
CART complex components led to the suggestion that fast recycling of TfR may be impaired [76], 
indicated here by dashed arrows/question marks. EE, early endosome; RE, recycling endosome. 
 
 
